Immunomodulatory potential of mesenchymal stem cell role in diseases and therapies: A bioengineering prospective

[1]  Francesca Taraballi,et al.  Biomimetic Tissue Engineering: Tuning the Immune and Inflammatory Response to Implantable Biomaterials , 2018, Advanced healthcare materials.

[2]  S. Wan,et al.  FAK- and YAP/TAZ dependent mechanotransduction pathways are required for enhanced immunomodulatory properties of adipose-derived mesenchymal stem cells induced by aligned fibrous scaffolds. , 2018, Biomaterials.

[3]  K. Le Blanc,et al.  MSCs-cells with many sides. , 2018, Cytotherapy.

[4]  E. Tasciotti,et al.  Corrigendum: Heparan Sulfate: A Potential Candidate for the Development of Biomimetic Immunomodulatory Membranes , 2018, Front. Bioeng. Biotechnol..

[5]  E. Tasciotti,et al.  Immune tuning scaffold for the local induction of a pro-regenerative environment , 2017, Scientific Reports.

[6]  E. Tasciotti,et al.  Concise Review: Biomimetic Functionalization of Biomaterials to Stimulate the Endogenous Healing Process of Cartilage and Bone Tissue , 2017, Stem cells translational medicine.

[7]  Nupur Basu,et al.  Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation , 2017, Scientific Reports.

[8]  S. Goodman,et al.  Mesenchymal stem cells homing to improve bone healing , 2017, Journal of orthopaedic translation.

[9]  S. Glynn,et al.  Mesenchymal stem cells: key players in cancer progression , 2017, Molecular Cancer.

[10]  M. Ferrari,et al.  Chondroitin Sulfate Immobilized on a Biomimetic Scaffold Modulates Inflammation While Driving Chondrogenesis , 2016, Stem cells translational medicine.

[11]  Yeyang Su,et al.  Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective. , 2016, Social science & medicine.

[12]  K. Tarte,et al.  Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin. , 2015, Tissue engineering. Part A.

[13]  K. Whartenby,et al.  Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. , 2014, World journal of stem cells.

[14]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[15]  K. Kang,et al.  Mesenchymal stem cells and cancer: friends or enemies? , 2014, Mutation research.

[16]  H. Shim,et al.  Intra‐Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof‐of‐Concept Clinical Trial , 2014, Stem cells.

[17]  J. Karp,et al.  Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.

[18]  David J. Williams,et al.  Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. , 2013, British medical bulletin.

[19]  Mehmet Fatih Yanik,et al.  mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. , 2013, Blood.

[20]  A. Vacca,et al.  Evidence for Bone Marrow Adult Stem Cell Plasticity: Properties, Molecular Mechanisms, Negative Aspects, and Clinical Applications of Hematopoietic and Mesenchymal Stem Cells Transdifferentiation , 2013, Stem cells international.

[21]  I. Date,et al.  Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma , 2012, Cancer Gene Therapy.

[22]  Lixin Wei,et al.  The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth , 2012, Cell & Bioscience.

[23]  Jeffrey M Karp,et al.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. , 2012, Cell stem cell.

[24]  Jing Yang,et al.  Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors , 2011, Gene Therapy.

[25]  A. Bayat,et al.  Exploring the application of mesenchymal stem cells in bone repair and regeneration. , 2011, The Journal of bone and joint surgery. British volume.

[26]  E. Wiertz,et al.  Exploitation of Herpesvirus Immune Evasion Strategies to Modify the Immunogenicity of Human Mesenchymal Stem Cell Transplants , 2011, PloS one.

[27]  L. Rhodes,et al.  Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk , 2010, Molecular Cancer.

[28]  C. De Bari,et al.  The regulation of differentiation in mesenchymal stem cells. , 2010, Human gene therapy.

[29]  Y. Xia,et al.  Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice , 2010, Oncogene.

[30]  A. Quiñones‐Hinojosa,et al.  The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research. , 2010, Current immunology reviews.

[31]  K. Kaur,et al.  Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway , 2010, PloS one.

[32]  Ruth S. Waterman,et al.  A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.

[33]  P. Leung,et al.  Influence of the prodrugs 5‐fluorocytosine and CPT‐11 on ovarian cancer cells using genetically engineered stem cells: tumor‐tropic potential and inhibition of ovarian cancer cell growth , 2010, Cancer science.

[34]  P. Hematti,et al.  Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. , 2009, Experimental hematology.

[35]  G. Daley,et al.  Bone marrow adipocytes as negative regulators of the hematopoietic microenvironment , 2009, Nature.

[36]  A. Kate Sasser,et al.  Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.

[37]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[38]  Eun Hye Lim,et al.  Hyperthermia‐treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line , 2009, Cancer.

[39]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[40]  S. Morrison,et al.  Uncertainty in the niches that maintain haematopoietic stem cells , 2008, Nature Reviews Immunology.

[41]  Yuquan Wei,et al.  A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Zhili Xu,et al.  Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model , 2008, Cell Research.

[43]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[44]  P. Neth,et al.  Scientific category: Stem cells in hematology MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines , 2006 .

[45]  Karim Oudina,et al.  Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. , 2007, Bone.

[46]  E. Jones,et al.  The role of mesenchymal stem cells in maintenance and repair of bone. , 2007, Injury.

[47]  R. Schwinger,et al.  Mesenchymal stem cells transmigrate over the endothelial barrier. , 2006, European journal of cell biology.

[48]  Lindolfo da Silva Meirelles,et al.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.

[49]  M. Raffeld,et al.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.

[50]  W. Ansorge,et al.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. , 2005, Experimental hematology.

[51]  D. García-Olmo,et al.  A Phase I Clinical Trial of the Treatment of Crohn’s Fistula by Adipose Mesenchymal Stem Cell Transplantation , 2005, Diseases of the colon and rectum.

[52]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[53]  M. Andreeff,et al.  Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. , 2004, Journal of the National Cancer Institute.

[54]  K. Alitalo,et al.  Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. , 2004, Blood.

[55]  Keisuke Ito,et al.  Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.

[56]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.

[57]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  H. Lorenz,et al.  Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. , 2002, Plastic and reconstructive surgery.

[59]  S. Gronthos,et al.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Herrmann,et al.  A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[61]  H. Kupcová Skalníková.  Proteomic techniques for characterisation of mesenchymal stem cell secretome. , 2013, Biochimie.

[62]  B. Hennessy,et al.  Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors , 2011, Cellular Oncology.

[63]  D. Gisselsson,et al.  Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.